Fibrinolysis Using Monotherapy is Inadequate and Risky

Abstract

Affiliation: Director, Vascular Research Laboratory, Harvard Medical School, Mt Auburn Hospital, Cambridge, Massachusetts, United States Corresponding author: Gurewich V, Director, Vascular Research Laboratory, Harvard Medical School, Mt Auburn Hospital, Cambridge, Massachusetts, United States, E-mail: vgurewich@tsillc.net Citation: Gurewich V. Fibrinolysis using monotherapy is inadequate and risky (2019) Neurophysio and Rehab 2: 26-28 Received: Apr 19, 2019 Accepted: May 24, 2019 Published: May 28, 2019 Copyright: © 2019 Gurewich V. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.